Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease.
about
Endogenous opiates and behavior: 2006Prevalence of wearing-off and dyskinesia among the patients with Parkinson's disease on levodopa therapy: a multi-center registry survey in mainland ChinaPharmacogenetics of antiparkinsonian drug treatment: a systematic review.Pharmacogenetics of Parkinson's disease - through mechanisms of drug actions.Pharmacogenomics of the human µ-opioid receptor.Pharmacological treatment and the prospect of pharmacogenetics in Parkinson's disease.Pharmacogenomics in neurology: current state and future steps.A systematic review of the A118G (Asn40Asp) variant of OPRM1 in relation to smoking initiation, nicotine dependence and smoking cessation.Anti-Parkinson's disease drugs and pharmacogenetic considerations.Parkinson's disease pharmacogenomics: new findings and perspectives.Pharmacogenetics of drug response in Parkinson's disease.Pharmacogenetic considerations in the treatment of Parkinson's disease.A review of adverse events linked to dopamine agonists in the treatment of Parkinson's disease.How close are we to individualized medicine for Parkinson's disease?Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.A systematic review and integrative approach to decode the common molecular link between levodopa response and Parkinson's diseaseFast-scan cyclic voltammetry demonstrates that L-DOPA produces dose-dependent regionally selective, bimodal effects on striatal dopamine kinetics in vivo.Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory study.Dopamine receptors and BDNF-haplotypes predict dyskinesia in Parkinson's disease.Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies.Can Astrocytes Be a Target for Precision Medicine?Sequence variants in SLC6A3, DRD2, and BDNF genes and time to levodopa-induced dyskinesias in Parkinson's disease.From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms.Gender effect on time to levodopa-induced dyskinesias.Motor Complications of Dopaminergic Medications in Parkinson's Disease.
P2860
Q28752585-8790027D-5458-4C97-B48A-13F203151DBFQ35069101-10EDDD89-ABE5-4959-9BC1-E55C35017D0CQ36730631-C7F481F8-7475-4699-BCED-E7AAEF1E7BEFQ37583417-571CD7C0-8EE8-43DA-816C-017A10DF891BQ37932516-000FBE90-9D67-467F-B972-FDD1309CA917Q37957393-68BE9035-ABE1-4AAE-A654-641F5D1DE99BQ37967607-C93CA052-E9A6-462A-AF20-1413472CE73FQ38016946-95678F8B-6D5A-401C-A62E-28E3D39F7E8BQ38097097-FA75A800-C3BB-49D7-A15E-0F80CFAB045EQ38241678-76F4EBE5-9A0E-4062-9E8D-B0799B1AD3FEQ38250117-591AB628-4AA0-4E24-B135-C3C8751C2487Q38364825-F1CDD112-807E-4068-9AAA-0D0A30E2EF70Q38662579-B4FAC14E-5929-4638-AD15-7AF1DA79ED46Q38814888-7CDCF2AF-535A-4C89-AA6F-98DF51D8A229Q38865983-47B17ADB-E145-4FFD-9B46-1C3C8ED26472Q41711967-8B1676C0-9B89-4AA2-9BA0-5D4FFD5586CDQ42754446-31B77E97-5181-4E5A-A84E-08C35FBDF361Q45007058-420D7576-8008-4918-A6C0-D27B0B62243DQ47389217-65AA10EC-70E6-4187-8E9A-E4A765765A66Q47648607-B096C40D-3092-4E9C-BF8D-C014EC2BB93FQ48140499-52449CA1-9172-4B30-9B1C-13624804F0B7Q48880365-522F222D-A12C-4BE5-8356-234DE8D2BC60Q49197356-619A0FC2-0C16-4DAC-9BB6-A32C799D41F4Q51469422-F49BBED0-ED49-49B2-83BC-01F58403D7B4Q55279095-8A29AD67-5773-4A75-A5C7-B2165BA187F1
P2860
Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Genotype and smoking history a ...... nesias in Parkinson's disease.
@en
Genotype and smoking history a ...... nesias in Parkinson's disease.
@nl
type
label
Genotype and smoking history a ...... nesias in Parkinson's disease.
@en
Genotype and smoking history a ...... nesias in Parkinson's disease.
@nl
prefLabel
Genotype and smoking history a ...... nesias in Parkinson's disease.
@en
Genotype and smoking history a ...... nesias in Parkinson's disease.
@nl
P2093
P921
P356
P1433
P1476
Genotype and smoking history a ...... inesias in Parkinson's disease
@en
P2093
Arif Dalvi
Frederick J Samaha
Fredy J Revilla
Jeffrey A Welge
Jianhua Gong
Judith A Strong
Maureen Gartner
P2860
P304
P356
10.1002/MDS.20785
P407
P50
P577
2006-05-01T00:00:00Z